**Core Concept**
Fibrocystic disease of the breast, also known as fibrocystic change or fibrocystic breast disease, is a common condition characterized by lumpy or rope-like breast tissue, which can cause discomfort and pain in some women. The pathophysiology of this condition is linked to the hormonal fluctuations that occur throughout the menstrual cycle.

**Why the Correct Answer is Right**
Fibrocystic disease of the breast is primarily influenced by hormonal factors, particularly the fluctuations in estrogen and progesterone levels during the menstrual cycle. Estrogen promotes the growth of breast tissue, leading to the development of cysts and fibrous tissue. The increased estrogen levels in the breast tissue can cause the formation of fluid-filled cysts and fibrous nodules, which are characteristic features of fibrocystic disease. This condition is more common in premenopausal women, where estrogen levels are high.

**Why Each Wrong Option is Incorrect**
**Option A:** Testosterone is a male sex hormone that plays a minor role in female reproductive health, but it is not directly associated with the development of fibrocystic disease of the breast.
**Option B:** Progesterone is another hormone that contributes to the menstrual cycle, but its levels are not as directly linked to the development of fibrocystic disease as estrogen is.
**Option D:** Luteinizing hormone is a hormone produced by the pituitary gland that stimulates ovulation, but it is not directly associated with the development of fibrocystic disease of the breast.

**Clinical Pearl / High-Yield Fact**
It's essential to note that fibrocystic disease of the breast is a benign condition and is not associated with an increased risk of breast cancer. However, it's crucial for patients to undergo regular breast examinations and mammograms to rule out any potential malignancies.

**✓ Correct Answer: C. Estrogen**